Anti-CAB39/MO25 antibody [EP1680Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal CAB39/MO25 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 14 publications.
View Alternative Names
MO25, CGI-66, CAB39, Calcium-binding protein 39, MO25alpha, Protein Mo25
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CAB39/MO25 antibody [EP1680Y] (AB51132)
Immunofluorescent staining of HeLa cells using ab51132 (1 : 100).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CAB39/MO25 antibody [EP1680Y] (AB51132)
ab51132 (1 : 100) staining human CAB39/MO25 in human brain tissue by immunohistochemistry using paraffin embedded tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CAB39/MO25 antibody [EP1680Y] (AB51132)
Overlay histogram showing HeLa cells stained with ab51132 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab51132 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- WB
Unknown
Western blot - Anti-CAB39/MO25 antibody [EP1680Y] (AB51132)
All lanes:
Western blot - Anti-CAB39/MO25 antibody [EP1680Y] (ab51132) at 1/20000 dilution
All lanes:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP labeled at 1/2000 dilution
Predicted band size: 40 kDa
Observed band size: 35 kDa
false
Related conjugates and formulations (1)
-
Anti-CAB39/MO25 antibody [EP1680Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CAB39 influences several cellular processes by acting as a scaffolding protein. It is an integral component of the LKB1-STRAD-MO25 complex essential for proper kinase activity. This complex regulates AMPK signaling pathways which are important for cellular energy homeostasis and metabolism. CAB39 by interacting with these kinases regulates energy balance within cells particularly muscle and liver tissues. This regulation influences cell polarity and growth impacting cell survival and division.
Pathways
CAB39 is significant in both the AMPK and mTOR signaling pathways playing a role in energy sensing and cellular growth regulation. In these pathways CAB39 modulates the activity of proteins like AMPK and LKB1. The AMPK pathway is important for maintaining energy homeostasis and is activated under low energy conditions while the mTOR pathway relates to cell growth and autophagy. CAB39’s role in these pathways highlights its importance in controlling metabolic responses to nutrient availability and stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Environmental toxicology 39:4791-4802 PubMed39171884
2024
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:159 PubMed37080995
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37047258
2023
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation and regeneration 42:24 PubMed35915511
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:9855-9871 PubMed35412939
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Renal physiology 320:F908-F921 PubMed33779313
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2021:6616240 PubMed33505470
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 19:e13128 PubMed32196916
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2020:1645249 PubMed32256945
2020
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 122:705-714 PubMed31919406
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com